Literature DB >> 18438950

Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions.

Elizabeth A Young1, Christie D Fowler, Grahame J Kidd, Ansi Chang, Richard Rudick, Elizabeth Fisher, Bruce D Trapp.   

Abstract

OBJECTIVE: Degeneration of chronically demyelinated axons is a major cause of irreversible neurological decline in the human central nervous system disease, multiple sclerosis (MS). Although the molecular mechanisms responsible for this axonal degeneration remain to be elucidated, dysfunction of axonal Na+/K+ ATPase is thought to be central. To date, however, the distribution of Na+/K+ ATPase has not been studied in MS lesions.
METHODS: The percentage of axons with detectable Na+/K+ ATPase was determined in 3 acute and 36 chronically demyelinated lesions from 13 MS brains. In addition, we investigated whether postmortem magnetic resonance imaging profiles could predict Na+/K+ ATPase immunostaining in a subset (20) of the chronic lesions.
RESULTS: Na+/K+ ATPase subunits alpha1, alpha3, and beta1 were detected in the internodal axolemma of myelinated fibers in both control and MS brains. In acutely demyelinated lesions, Na+/K+ ATPase was detectable on demyelinated axolemma. In contrast, 21 of the 36 chronic lesions (58%) contained less than 50% Na+/K+ ATPase-positive demyelinated axons. In addition, magnetic resonance imaging-pathology correlations of 20 chronic lesions identified a linear decrease in the percentage of Na+/K+ ATPase-positive axons and magnetization transfer ratios (p < 0.0001) and T1 contrast ratios (p < 0.0006).
INTERPRETATION: Chronically demyelinated axons that lack Na+/K+ ATPase cannot exchange axoplasmic Na+ for K+ and are incapable of nerve transmission. Loss of axonal Na+/K+ ATPase is likely to be a major contributor to continuous neurological decline in chronic stages of MS, and quantitative magnetization transfer ratios and T1 contrast ratios may provide a noninvasive surrogate marker for monitoring this loss in MS patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438950     DOI: 10.1002/ana.21381

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

1.  Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Authors:  Natalia M Moll; Anna M Rietsch; Smitha Thomas; Amy J Ransohoff; Jar-Chi Lee; Robert Fox; Ansi Chang; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

Review 2.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

3.  Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.

Authors:  Bruce D Trapp; Megan Vignos; Jessica Dudman; Ansi Chang; Elizabeth Fisher; Susan M Staugaitis; Harsha Battapady; Sverre Mork; Daniel Ontaneda; Stephen E Jones; Robert J Fox; Jacqueline Chen; Kunio Nakamura; Richard A Rudick
Journal:  Lancet Neurol       Date:  2018-08-22       Impact factor: 44.182

4.  The energetics of CNS white matter.

Authors:  Julia J Harris; David Attwell
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

5.  Activity-dependent regulation of mitochondrial motility by calcium and Na/K-ATPase at nodes of Ranvier of myelinated nerves.

Authors:  Chuan Li Zhang; Po Lai Ho; Douglas B Kintner; Dandan Sun; Shing Yan Chiu
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

Review 6.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

Review 7.  Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.

Authors:  Pradip K Kamat; Anuradha Kalani; Philip Kyles; Suresh C Tyagi; Neetu Tyagi
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

8.  Effects of the noradrenergic system in rat white matter exposed to oxygen-glucose deprivation in vitro.

Authors:  Maria A Nikolaeva; Sandra Richard; Abdeslam Mouihate; Peter K Stys
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

Review 9.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.